Prosecution Insights
Last updated: October 25, 2026

Cosmax Inc.

Technology area: Biotechnology & Pharmaceuticals

6 pending office actions • 6 art units • 6 examiners • 0 of 6 (0%) have an AI response strategy ready • 4 patents granted in the last 365 days

Analysis

Cosmax Inc. has 6 pending office actions in Biotechnology & Pharmaceuticals. The matters involve 6 distinct examiners and 6 distinct art units, indicating that every pending matter is assigned across a separate examiner and technical unit.

ERICKSON, BENNETT S is the busiest examiner, with 1 pending office action. No examiner handles more than that one matter in the provided profile, so counsel should organize prosecution around application-specific records rather than a shared examiner relationship.

The distribution calls for coordinated portfolio oversight, especially when biotechnology or pharmaceutical claim themes recur across applications. Counsel can maintain consistent positions while adapting each response to the applicable examiner and art-unit context.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

6
Total Pending OAs
2
Non-Final OAs
4
Final Rejections
0
Advisory / Quayle

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

2
Hard (33%)
4
Medium (67%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 + other1 (17%)
§103 only4 (67%)
Multi-statute (no §101)1 (17%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

5
Life Sciences
83% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
1
Mechanical / Eng
17% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

60 h
Manual time on pending OAs
12 h
Time saved (low, 20%)
21 h
Time saved (mid, 35%)
0.5 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
ERICKSON, BENNETT S 1 38.2% +43.6%
GOTFREDSON, GAREN 1 39.9% +28.1%
KIM, DANIELLE A 1 36.6% +51.9%
TRAN, SUSAN T 1 63.0% +34.8%
YU, HONG 1 31.1% +5.7%
JUSTICE, GINA CHIEUN YU 1 55.6% +8.5%

Hard Cases (2)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.

App #TitleExaminerDue in
18832151 DEVICE AND METHOD FOR PROVIDING SKIN INFORMATION ON BASIS OF SKIN MICROBIOME ERICKSON, BENNETT S —
18760910 ETHER/ESTER COMPOSITE POLYURETHANE FOAM COSMETIC GOTFREDSON, GAREN —

Interview Candidates (4)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 4 ordered by deadline are shown.

App #TitleExaminerDue in
18832151 DEVICE AND METHOD FOR PROVIDING SKIN INFORMATION ON BASIS OF SKIN MICROBIOME ERICKSON, BENNETT S —
18760910 ETHER/ESTER COMPOSITE POLYURETHANE FOAM COSMETIC GOTFREDSON, GAREN —
18702941 POROUS SILICA IMPREGNATED WITH EPIDERMIDIBACTERIUM KERATINI EXTRACT AND USE THEREOF FOR IMPROVING SKIN CONDITION KIM, DANIELLE A —
18293249 COSMETIC COMPOSITION FOR ENHANCING SKIN ABSORPTION TRAN, SUSAN T —

Top Art Units

Art UnitApps
3683 1
1619 1
1613 1
1615 1
1614 1
1617 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18832151 DEVICE AND METHOD FOR PROVIDING SKIN INFORMATION ON BASIS OF SKIN MICROBIOME ERICKSON, BENNETT S 3683 §101§103 Final Rejection — Pending Jul 23, 2024
18760910 ETHER/ESTER COMPOSITE POLYURETHANE FOAM COSMETIC GOTFREDSON, GAREN 1619 §103§112 Final Rejection — Pending Jul 01, 2024
18702941 POROUS SILICA IMPREGNATED WITH EPIDERMIDIBACTERIUM KERATINI EXTRACT AND USE THEREOF FOR IMPROVING SKIN CONDITION KIM, DANIELLE A 1613 §103 Final Rejection — Pending Apr 19, 2024
18293249 COSMETIC COMPOSITION FOR ENHANCING SKIN ABSORPTION TRAN, SUSAN T 1615 §103 Final Rejection — Pending Jan 29, 2024
18288508 HIGH-HARDNESS LIQUID CRYSTAL COSMETIC COMPOSITION HAVING ELASTIC TEXTURE AND METHOD FOR PREPARING SAME YU, HONG 1614 §103 Non-Final OA — Pending Oct 26, 2023
18214553 COSMETIC COMPOSITION INCLUDING GARLIC EXTRACT, BLACK TEA EXTRACT, AND GUAVA EXTRACT JUSTICE, GINA CHIEUN YU 1617 §103 Non-Final OA — Pending Jun 27, 2023

Managing Cosmax Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

How many pending USPTO office actions does Cosmax Inc. have?

Cosmax Inc. has 6 pending office actions as of October 2026, spread across 6 art units and 6 examiners.

Which USPTO examiner handles the most Cosmax Inc. applications?

Bennett S Erickson has the most, with 1 of Cosmax Inc.'s pending office actions.

What technology area are Cosmax Inc.'s patent applications in?

Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month